Opposite effects of the CD30 ligand are not due to CD30 mutations: Results from cDNA cloning and sequence comparison of the CD30 antigen from different sources

This publication has 13 references indexed in Scilit:

• Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines
  Blood, 1994
• Cultured human NK cells express the Ki-l/CD30 antigen
  British Journal of Haematology, 1993
• CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
  Cell, 1993
• Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
  Cell, 1992
• The Clinical Significance of Cytokines and Soluble Forms of Membrane-Derived Activation Antigens in the Serum of Patients with Hodgkin's Disease
  Leukemia & Lymphoma, 1992
• Polymerase chain reaction amplification and sequence analysis of human mutant adenine phosphoribosyltransferase genes: The nature and frequency of errors caused by Taq DNA polymerase
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
• Deletion mutagenesis during polymerase chain reaction: dependence on DNA polymerase
  Gene, 1991
• Fc gamma R(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes.
  The Journal of Experimental Medicine, 1989
• A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene
  Blood, 1988
• Hodgkin's disease: Establishment and characterization of four in vitro cell lines
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1981